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H
DObjective: The purpose of this study was to develop risk models for congenital heart surgery short-term and
midterm outcomes from a nationwide integrated database drawn from hospitals in Japan.
Methods: The Japan Congenital Cardiovascular Surgery Database collects clinical information from institu-
tions throughout Japan specializing in congenital heart surgery. Variables and definitions used in the Japan
Congenital Cardiovascular Surgery Database are almost identical to those of the Society of Thoracic Sur-
geons–European Association for Cardiothoracic Surgery database for congenital heart surgery. We used logistic
regression to develop risk models, which were then validated through spilt-sample validation. In addition to pro-
cedural complexity categories by Risk Adjustment in Congenital Heart Surgery (RACHS-1) score, we incorpo-
rated patient characteristics to predict surgical outcome.
Results: Among 8923 congenital heart operations performed at 69 sites with cardiac surgical programs, 30-day
mortalities by RACHS-1 category were as follows: I, 0.1% (n ¼ 1319); II, 0.5% (n ¼ 3211); III, 2.2%
(n¼ 3285); IV, 4.3% (n¼ 818); and Vand VI, 8.6% (n¼ 290). From the test data set (n¼ 7223), we developed
3 risk models (30-day mortality, 90-day mortality, and 90-day and in-hospital mortality) with 11 variables,
including age category, RACHS-1 category, preoperative risk factors, number of surgical procedures, unplanned
reoperations, status of surgery, surgery type, asplenia, and prematurity (<35 weeks). For the performance met-
rics of the risk models, C statistic values of 30-day, 90-day, and 90-day and in-hospital mortalities for the test
data set were 0.85, 0.85, and 0.84, respectively. When only the RACHS-1 score was used for discrimination,
the C statistic values of 30-day, 90-day, and 90-day and in-hospital mortalities for the validation data set
were 0.73, 0.73, and 0.77, respectively.
Conclusions: The proposed risk scores and categories have high discrimination power for predicting mortality,
demonstrating improvement relative to existing consensus-based methods. Risk models incorporating these
measures may be useful for comparing mortality outcomes cross institutions or countries with mixed cases.
(J Thorac Cardiovasc Surg 2014;148:2201-6)See related commentary on pages 2206-7.Congenital heart surgery is one of the most challenging
areas in the entire field of surgery. This may be particularly
true for open palliative procedures with cardiopulmonary
bypass in immature neonates with complex congenital heart
disease. Open repair in adult patients with congenital hearte Japan Cardiovascular Surgery Database Organization, Tokyo, Japan.
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The Journal of Thoracic and Cardisease also carries a high risk associated with multiorgan
dysfunction because of long-standing cyanosis. The Society
of Thoracic Surgeons–European Association for Cardiotho-
racic Surgery database for congenital heart surgery lists 148
types of surgical procedures.1 The need to establish clinical
registries and quantitative tools for responsible outcome re-
porting has been recognized.
Previous risk classification of complex congenital heart
surgery has been based on complexity scores, rather than
surgical procedure-based classification. Satisfactory mor-
tality prediction can be achieved with Society of Thoracic
Surgeons–European Association for Cardiothoracic Sur-
gery scores and categories (C statistics 0.784 and 0.733,
respectively).1 With respect to procedural complexity, the
Risk Adjustment in Congenital Heart Surgery (RACHS-
1)2,3 and Aristotle4,5 basic scores are used in the Society
of Thoracic Surgeons and European Association for
Cardiothoracic Surgery databases.6 Each score is decided
on by a committee composed of specialists, meaning that
it is derived from subjective indicators that do not accountdiovascular Surgery c Volume 148, Number 5 2201
Abbreviations and Acronyms
JCCVSD ¼ Japan Congenital Cardiovascular
Surgery Database
RACHS-1 ¼ Risk Adjustment in Congenital Heart
Surgery
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Congenital Heart Disease Miyata et alfor patient factors.2-5 In this study, we examined the validity
of risk stratification according to procedural complexity by
using data. The development of an objective model with
high reproducibility is desired for benchmarking
purposes.7,8 In addition to incorporating the procedural
complexity indicators mentioned previously, we also
included patient-derived risk factors to develop an explana-
tory, objective model. Moreover, whereas previous studies
have used in-hospital mortality for benchmarking,9 we
also incorporated 90-day mortality to assess longer-term
outcomes than previously addressed.MATERIALS AND METHODS
Study Population
In 2000, the Japanese Society for Cardiovascular Surgery established a
nationwide database to assess surgical outcomes after cardiovascular surgery.
In 2008, the Society launched the Japan Congenital Cardiovascular Surgery
Database (JCCVSD) for congenital heart surgery.10 The JCCVSD currently
collects clinical information from 82 Japanese institutions specializing in
congenital heart disease, covering almost all major congenital heart surgery
programs in Japan. Each participating hospital has received the appropriate
approval from the respective institutional review board.
Eight-two sites have participated in the JCCVSD, and 64 sites of
these sites submitted the data of 2008 through 2010. Items in the data-
base include demographic information, cardiac and noncardiac anoma-
lies, comorbid conditions, and surgical type and outcomes. Definitions
of these variables are essentially identical to those of the Society of
Thoracic Surgeons database11 (definitions are available online at
http://sts.org). The JCCVSD has developed a web-based data-
collection software system through which the data manager of each
participating hospital can electronically submit data to the central of-
fice. Validity of the data sets has been confirmed by an independent
comparison of the volume of cardiac surgery at a particular hospital
entered in the JCCVSD versus that reported to the Japanese Association
for Thoracic Surgery annual survey.12
We examined all congenital heart surgical procedures reported between
August 1, 2008, and December 31, 2010. JCCVSD records obtained
without patient consent were excluded from this analysis. We included
9401 records with age (or age range), sex, and 90-day status and excluded
2045 for which the RACHS-1 score was unavailable. On the basis of
RACHS-1 scores,2,3 we included only the operation with the highest
RACHS-1 score for each hospital admission, excluding other surgical pro-
cedures (n¼ 478) within the same admission. In the end, the population for
this analysis comprised 8923 congenital heart surgical procedures from 69
participating institutions throughout Japan.
With respect to risk factors, although the vast majority of JCCVSD pa-
tient are young, there are some adult congenital heart surgical cases.
Although we added age category as a general risk factor, it is better to
add acquired risk factors when assessing the adult population. Further
researchmight better to consider this matter. Also, because of the limitation
of low event rate, we used a large category of preoperative risk factor to
examine risk in the JCCVSD at the initial phase.2202 The Journal of Thoracic and Cardiovascular SurEnd Points
The primary outcomemeasure of JCCVSDwas 30-daymortality, which
included any patient who died during the index hospitalization as of day 30
after the operation, regardless of the length of the hospital stay, and any pa-
tient who died after being discharged from the hospital within 30 days of the
operation. The secondary outcomes of the JCCVSD were 90-day mortality
and 90-day and in-hospital mortality. The 90-day mortality was defined as
death within 90 days after the operation, regardless of in-hospital or out-of-
hospital status. The 90-day and in-hospital mortality included any death
during the index hospitalization, regardless of length of hospital stay, and
any death occurring out of the hospital within 90 days after surgery.
Statistical Analysis
Data (n ¼ 8923) were randomly divided into 2 subsets for model
development, the test data set (7223 records; 80%) and the validation
data set (1700 records; 20%). For the test data set, multivariate stepwise
logistic regression analysis (forward inclusion method) was performed
for each outcome. For the validation data set, the area under the receiver
operating characteristic curve13 was used to assess the discrimination
power of the risk model for predicting patient mortality. Model
calibration (the degree of similarity between observed outcomes and
outcomes predicted by the model, compared across patient groups)
was examined by comparing the observed and predicted averages
within each of equally sized subgroups arranged in increasing order
of patient risk.RESULTS
Risk Profile of the Study Population
The patient population (total JCCVSD records, n¼ 8923)
was classified according to RACHS-1 category2,3 (category
I, 1319; category II, 3211; category III, 3285; category IV,
818; category V, 4; and category VI, 286; Table 1). Of the
patient population, 51.5% were male; 13.7% were neo-
nates, 37.5% were infants, and 5.6% were adults; 26.8%
were undergoing palliative operations and 73.2% were un-
dergoing corrective operations; 6.2% had a birth weight
lower than 2000 g; 2.2% were undergoing noninitial proce-
dures; 68.4% were undergoing procedures with any preop-
erative risk factor; 2.1% had asplenia syndrome; and 0.5%
were born at 32 to 35 weeks’ gestation. The average hospital
stays were 25.7  37.3 days in the test data set and 26.0 
41.2 days in the validation data set.Outcome Rates
Table 2 shows an abbreviated risk profile for the JCCVSD
study population. Outcome rates associated with congenital
heart surgery were 1.7% for 30-day mortality, 2.4% for 90-
day mortality, and 2.8% for 90-day and in-hospital mortal-
ity. Outcome rates by RACHS-1 score (category I, II, III, IV,
and V and VI combined) for 30-day mortality were 0.1%,
0.5%, 2.2%, 4.3%, and 8.6%, respectively; those for 90
day and in-hospital mortality were 0.2%, 0.7%, 3.0%,
5.5%, and 15.2%, respectively.Model Results
Three different risk models (30-day mortality, 90-day
mortality, and 90-day and in-hospital mortality) weregery c November 2014
TABLE 1. Patient characteristics (n ¼ 8923)
Test data set
(n ¼ 7223)
Validation data set
(n ¼ 1700) P
valuen % n %
RACHS-1 category .989
I 1061 14.7 258 15.2
II 2601 36.0 610 35.9
III 2663 36.9 622 36.6
IV 663 9.2 155 9.1
V 3 0.04 1 0.1
VI 232 3.2 54 3.2
Age
<28 d 980 13.6 241 14.2 .505
28 d-1 y 2695 37.3 654 38.5 .373
1-18 y 3144 43.5 704 41.4 .115
18 y 400 5.5 100 5.9 .598
Mortality
30-d 123 1.7 28 1.6 1.000
90-d 168 2.3 210 2.4 .722
In-hospital 204 2.8 48 2.8 1.000
90-d and in-hospital 223 3.1 57 3.4 .588
Male sex 3694 51.1 904 53.2 .138
Preterm pregnancy 572 7.9 144 8.5 .457
Fetal diagnosis 1251 17.3 289 17.0 .775
Birth weight<2000 g 444 6.1 111 6.5 .577
Any preoperative risk factor 4922 68.1 1185 69.7 .223
2 surgical procedures 159 2.2 39 2.3 .794
Unplanned reoperations 489 6.8 130 7.6 .203
2 hospitalizations 633 8.8 134 7.9 .269
Status of surgery
Urgent 567 7.8 126 7.4 .580
Emergency 148 2.0 48 2.8 .053
Surgery type
Without CPB 1182 16.4 264 15.5 .421
Nonradical 1933 26.8 456 26.8 .976
Asplenia 145 2.0 43 2.5 .188
Down syndrome 282 3.9 67 3.9 .945
Polysplenia 58 0.8 11 0.6 .644
Prematurity
<32 wk 14 0.2 5 0.3 .387
32-35 wk 33 0.5 8 0.5 1.000
RACHS-1, Risk Adjustment in Congenital Heart Surgery [score]; CPB, cardiopulmo-
nary bypass.
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95% confidence intervals are presented in Table 2. We
included 11 variables as adjustment factors for the final
risk models, such as age (<28 days and <28 days),
RACHS-1 category (I, II, III, IV, and V and VI combined),
birth weight (<2000 g), the presence of preoperative risk
factors, the number of procedure (>2), unplanned reoper-
ation, status of surgery (urgent and emergency), surgery
type (nonradical), asplenia, and prematurity (<35 weeks).
We defined a nonradical operation as any palliative oper-
ation. For example, nonradical operations would include
Blalock-Taussig shunt for cyanotic congenital heart
disease.The Journal of Thoracic and CarModel Performance
C statistic values for 30-day, 90-day, and 90-day and
in-hospital mortalities for the validation data set were
0.79, 0.81, and 0.84, respectively; for the test data set,
they were 0.83, 0.85, and 0.84 respectively. When only
the RACHS-1 score was used, C statistic values for
30-day, 90-day, and 90-day and in-hospital mortalities for
the validation data set were 0.73, 0.73, and 0.77, respec-
tively; for the test data set, they were 0.76, 0.78, and 0.77,
respectively.Observed Versus Predicted Mortality
The comparison of predicted and observed mortality by
risk categories for 30-day mortality, 90-day mortality, and
90-day and in-hospital mortality are shown in Figures 1
through 3. For 30-day mortality, observed mortality and
predicted mortality were 0.0072 and 0.0310 (risk>0.5%),
0.0050 and 0.0068 (0.5%-1.0%), 0.0063 and 0.0124
(1.9%-2.0%), 0.0318 and 0.0265 (2.0%-4.0%), 0.0710
and 0.0576 (4.0%-8.0%), and 0.1416 and 0.1792
(8.0%), respectively (Figure 1). For 90-day and in-
hospital mortality, observed mortality and predicted mortal-
ity were 0.0036 and 0.0049 (>1.0%), 0.0095 and 0.0143
(1.0%-2.0%), 0.0234 and 0.0308 (2.0%-4.0%), 0.0753
and 0.0642 (4.0%-8.0%), 0.1765 and 0.1277 (8.0%-
16.0%), and 0.2239 and 0.2964 (16.0%), respectively
(Figure 3).DISCUSSION
The risk model that incorporated patient characteristics
in procedural complexity categories was more discrimi-
nating than a model that solely used procedural complexity
categories. When only the RACHS-1 score was used,
discriminating power was relatively satisfactory at 0.73 to
0.77. This discriminating power was similar to that seen
with the population of the region in which RACHS-1 was
designed,3 suggesting that procedural complexity cate-
gories can also be applied to Japanese populations. More-
over, after incorporation of patient-derived factors such as
age categories, preoperative weight, and preoperative risk
factors, the C statistic values of models with 0.5 increased
tomore than 0.5, reflecting an increase in discriminating po-
wer. The mortality predicted by our risk model and the
observed mortality were similar in both low-risk and
high-risk groups, suggesting that our calibration was also
valid to a certain degree. These findings suggest that a
risk model that incorporates patient characteristics in proce-
dural complexity categories according to RACHS-1 pre-
sents a useful framework for calculating predicted
mortality.
In this study, a risk model was developed for 90-day
mortality and in-hospital mortality in addition to 30-day
mortality. A satisfactory 30-day mortality can be attributeddiovascular Surgery c Volume 148, Number 5 2203
TABLE 2. Description of risk models (n ¼ 7223)
30-d mortality 90-d mortality 90-d and in-hospital mortality
OR 95% CI OR 95% CI OR 95% CI
Age<28 d 2.21 1.47-3.32 1.88 1.28-2.75 2.25 1.64-3.09
RACHS-1 category (I, II, III, IV, and V plus VI) 1.98 1.62-2.43 2.35 1.97-2.82 2.08 1.76-2.48
Birth weight<2000 g — — 2.23 1.32-3.78 1.99 1.21-3.26
Any preoperative risk factor 2.31 1.36-3.91 1.80 1.17-2.77 1.94 1.34-2.82
2 surgical procedures — — — — 1.96 1.19-3.22
Unplanned reoperations 1.96 1.10-3.57 2.00 1.18-3.38 2.12 1.34-3.36
Status of surgery
Urgent — — 1.56 1.00-2.44 — —
Emergency 4.13 2.34-7.28 4.52 2.62-7.77 3.46 2.12-5.65
Nonradical surgery 2.83 1.89-4.25 2.74 1.92-3.91 2.67 1.95-3.65
Asplenia — — — — 3.86 2.08-7.17
Prematurity 4.27 0.97-18.7 — — 4.39 1.51-12.8
OR, Odds ratio; CI, confidence interval; RACHS-1, Risk Adjustment in Congenital Heart Surgery [score].
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such as postoperative intensive care, and is reflected by
long-term hospitalization that lasts on average 1 month,
because mortality may be related to prolonged stay.14
This exemplifies the characteristics of the Japanese health
care system, and similar trends have been reported in the
field of adult cardiac surgery.15 Because long-term hospi-
talization is connected to the inefficient use of medical re-
sources,16 cost efficiency should also be considered in the
future. Moreover, most deaths within 90 days occurred
within the hospitalization period. This is connected to
the fact that there were fewer missing values for variables
that tend to be missing from foreign databases, such as
30-day mortality and 90-day mortality.17 Although there
is very little difference in included items and odds ratiosFIGURE 1. Predicted and observed 3
2204 The Journal of Thoracic and Cardiovascular Surfor risk models of 30-day mortality and 90-day and in-
hospital mortality, emergency surgery tends to have a rela-
tively large effect on 30-day mortality, whereas birth
weight and number of procedures tend to have a large ef-
fect on 90-day mortality. In light of the approximately 2-
fold gap between 30-day and 90-day mortalities, it will be
important to consider how to address patients who die
within this period.18
Although our risk models showed good performance,
there is still room for improvement. First, with respect to
90-day and in-hospital mortality, the model simultaneously
overestimated the risk in the group with a predicted mortal-
ity greater than 16% and underestimated the risk in the
group with a predicted mortality of 8% to 16%. Thus
improving accuracy for high-risk groups will be important.0-day mortality by risk categories.
gery c November 2014
FIGURE 2. Predicted and observed 90-day mortality by risk categories.
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Miyata et al Congenital Heart DiseaseSecond, a better risk model might also be developed by not
only restructuring highly complex procedural categories but
also considering patient characteristics that contribute to
high risk. Because of the limitation of low event rate, we
used large category, preoperative risk factor, to examine
risk in the JCCVSD in the initial phase. In addition,
although the vast majority of the JCCVSD patient are
youths, there are some adult congenital heart procedures.
Although we added age category as general risk factor, it
is better to add acquired risk factors when assessing the
adult population. Further research might allow us toFIGURE 3. Predicted and observed 90-day an
The Journal of Thoracic and Carconsider this matter more fully. For procedural complexity
categories, calibration was increased, and discrimination
did not differ when the categories were considered by
increasing order of patient risk rather than by using the
ordinal variables as each degree of complexity, which is
why the former strategy was used. Third, death was the
only outcome of this study. When considering the perfor-
mance of pediatric cardiac surgical practice in its entirety,
understanding complications is crucial.19 In this context,
focusing on complications and longer-term prognosis will
likely be an effective strategy.d in-hospital mortality by risk categories.
diovascular Surgery c Volume 148, Number 5 2205
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(JCCVSD) is to be congratulated for their important
contribution to congenital and pediatric cardiac care inthe domains of outcomes analysis and quality improve-
ment.1 The authors have described the development of
sophisticated congenital cardiac surgical risk models for
short-term and mid-term outcomes based on integrated
data from nationwide hospitals in Japan, using JCCVSD.
This contribution is important because it describes the
development of congenital cardiac surgical risk models
that add to extant risk models by both the incorporation of
several patient-specific variables and increased duration of
follow-up.
JCCVSD uses the same nomenclature (International
Pediatric and Congenital Cardiac Code) and data standards
that are used in the Society of Thoracic Surgeons
Congenital Heart Surgery Database (STS-CHSD) and the
European Association for Cardio-Thoracic Surgery
Congenital Heart Surgery Database (EACTS-CHSD).gery c November 2014
